Josef Madrigal, Shannon Richardson, Joseph Hadaya, Arjun Verma, Zachary Tran, Yas Sanaiha, Peyman Benharash
{"title":"Perioperative outcomes and readmissions following cardiac operations in kidney transplant recipients.","authors":"Josef Madrigal, Shannon Richardson, Joseph Hadaya, Arjun Verma, Zachary Tran, Yas Sanaiha, Peyman Benharash","doi":"10.1136/heartjnl-2022-321030","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Although kidney transplant (KTx) recipients are at significant risk for cardiovascular disease, outcomes following cardiac operations have been examined in limited series. The present study thus aimed to assess the impact of KTx on in-hospital perioperative outcomes and readmissions in a nationally representative cohort.</p><p><strong>Methods: </strong>All adults undergoing elective coronary artery bypass grafting, valve repair/replacement or a combination thereof were identified from the 2010-2018 Nationwide Readmissions Database. Patients were stratified by history of KTx. Transplant-capable centres were defined as hospitals performing at least one KTx annually. To perform risk-adjustment in assessing outcomes, multivariable regression models were developed.</p><p><strong>Results: </strong>Of an estimated 1 407 351 patients included for analysis, 0.2% (n=2849) were KTx recipients. Compared with the general cardiac surgical population, patients with prior KTx experienced higher adjusted odds of in-hospital mortality (adjusted OR (AOR) 2.44, 95% CI 1.72 to 3.47, p<0.001) and perioperative complication (AOR 1.67, 95% CI 1.44 to 1.94, p<0.001). Additionally, KTx was independently associated with greater readmission rates within 30 days (AOR 1.96, 95% CI 1.65 to 2.34, p<0.001) with kidney injury contributing significantly to the burden of rehospitalisation (4.6 vs 1.8%, p=0.005). In a subpopulation comprised of only KTx recipients, treatment at a transplant-capable centre reduced odds of kidney injury with non-transplant hospitals as reference (AOR 0.65, 95% CI 0.43 to 0.98, p=0.037).</p><p><strong>Conclusions: </strong>Kidney transplant recipients undergoing cardiac operations encounter significant risks compared with the general surgical population. Referral to transplant-capable centres should be explored to improve outcomes and to preserve allograft function in this population.</p>","PeriodicalId":9311,"journal":{"name":"British Heart Journal","volume":"108 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Heart Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/heartjnl-2022-321030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Although kidney transplant (KTx) recipients are at significant risk for cardiovascular disease, outcomes following cardiac operations have been examined in limited series. The present study thus aimed to assess the impact of KTx on in-hospital perioperative outcomes and readmissions in a nationally representative cohort.
Methods: All adults undergoing elective coronary artery bypass grafting, valve repair/replacement or a combination thereof were identified from the 2010-2018 Nationwide Readmissions Database. Patients were stratified by history of KTx. Transplant-capable centres were defined as hospitals performing at least one KTx annually. To perform risk-adjustment in assessing outcomes, multivariable regression models were developed.
Results: Of an estimated 1 407 351 patients included for analysis, 0.2% (n=2849) were KTx recipients. Compared with the general cardiac surgical population, patients with prior KTx experienced higher adjusted odds of in-hospital mortality (adjusted OR (AOR) 2.44, 95% CI 1.72 to 3.47, p<0.001) and perioperative complication (AOR 1.67, 95% CI 1.44 to 1.94, p<0.001). Additionally, KTx was independently associated with greater readmission rates within 30 days (AOR 1.96, 95% CI 1.65 to 2.34, p<0.001) with kidney injury contributing significantly to the burden of rehospitalisation (4.6 vs 1.8%, p=0.005). In a subpopulation comprised of only KTx recipients, treatment at a transplant-capable centre reduced odds of kidney injury with non-transplant hospitals as reference (AOR 0.65, 95% CI 0.43 to 0.98, p=0.037).
Conclusions: Kidney transplant recipients undergoing cardiac operations encounter significant risks compared with the general surgical population. Referral to transplant-capable centres should be explored to improve outcomes and to preserve allograft function in this population.
虽然肾移植(KTx)受者患心血管疾病的风险很大,但心脏手术后的结果已经在有限的系列中进行了研究。因此,本研究旨在评估KTx对全国代表性队列住院围手术期结局和再入院的影响。方法从2010-2018年全国再入院数据库中确定所有接受择期冠状动脉旁路移植术、瓣膜修复/置换术或两者结合的成年人。根据KTx病史对患者进行分层。有移植能力的中心被定义为每年至少进行一次KTx手术的医院。为了在评估结果时进行风险调整,我们开发了多变量回归模型。结果在纳入分析的1 407 351例患者中,0.2% (n=2849)为KTx受体。与一般心脏手术人群相比,既往有KTx的患者有更高的住院死亡率(调整OR (AOR) 2.44, 95% CI 1.72至3.47,p<0.001)和围手术期并发症(AOR 1.67, 95% CI 1.44至1.94,p<0.001)。此外,KTx与30天内更高的再入院率独立相关(AOR 1.96, 95% CI 1.65至2.34,p<0.001),肾损伤显著增加再入院负担(4.6 vs 1.8%, p=0.005)。在仅由KTx受体组成的亚群中,以非移植医院为参照,在具有移植能力的中心接受治疗降低了肾损伤的几率(AOR 0.65, 95% CI 0.43至0.98,p=0.037)。结论:与普通外科人群相比,接受心脏手术的肾移植受者存在显著的风险。转诊到有移植能力的中心应探讨,以改善结果和保持同种异体移植功能在这一人群。